Elevance Health Debt to Equity Ratio 2012-2025 | ELV
Current and historical debt to equity ratio values for Elevance Health (ELV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Elevance Health debt/equity for the three months ending December 31, 2025 was 0.70.
| Elevance Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $77.47B | $44.03B | 1.76 |
| 2025-09-30 | $78.67B | $44.08B | 1.79 |
| 2025-06-30 | $78.09B | $43.85B | 1.78 |
| 2025-03-31 | $77.10B | $42.62B | 1.81 |
| 2024-12-31 | $75.46B | $41.43B | 1.82 |
| 2024-09-30 | $72.65B | $43.88B | 1.66 |
| 2024-06-30 | $70.69B | $42.30B | 1.67 |
| 2024-03-31 | $71.18B | $40.71B | 1.75 |
| 2023-12-31 | $69.52B | $39.41B | 1.76 |
| 2023-09-30 | $71.94B | $38.54B | 1.87 |
| 2023-06-30 | $70.86B | $38.31B | 1.85 |
| 2023-03-31 | $71.58B | $37.46B | 1.91 |
| 2022-12-31 | $66.43B | $36.33B | 1.83 |
| 2022-09-30 | $66.98B | $36.04B | 1.86 |
| 2022-06-30 | $65.01B | $35.87B | 1.81 |
| 2022-03-31 | $64.46B | $36.03B | 1.79 |
| 2021-12-31 | $61.33B | $36.13B | 1.70 |
| 2021-09-30 | $62.25B | $35.81B | 1.74 |
| 2021-06-30 | $61.05B | $35.05B | 1.74 |
| 2021-03-31 | $61.77B | $33.92B | 1.82 |
| 2020-12-31 | $53.42B | $33.20B | 1.61 |
| 2020-09-30 | $52.65B | $33.92B | 1.55 |
| 2020-06-30 | $53.52B | $34.46B | 1.55 |
| 2020-03-31 | $50.71B | $31.69B | 1.60 |
| 2019-12-31 | $45.73B | $31.73B | 1.44 |
| 2019-09-30 | $46.48B | $31.33B | 1.48 |
| 2019-06-30 | $45.06B | $30.79B | 1.46 |
| 2019-03-31 | $44.53B | $30.00B | 1.48 |
| 2018-12-31 | $43.03B | $28.54B | 1.51 |
| 2018-09-30 | $45.35B | $29.09B | 1.56 |
| 2018-06-30 | $45.64B | $28.73B | 1.59 |
| 2018-03-31 | $46.29B | $27.01B | 1.71 |
| 2017-12-31 | $44.04B | $26.50B | 1.66 |
| 2017-09-30 | $42.36B | $25.95B | 1.63 |
| 2017-06-30 | $41.81B | $26.43B | 1.58 |
| 2017-03-31 | $42.85B | $26.09B | 1.64 |
| 2016-12-31 | $39.98B | $25.10B | 1.59 |
| 2016-09-30 | $39.66B | $24.74B | 1.60 |
| 2016-06-30 | $39.83B | $24.23B | 1.64 |
| 2016-03-31 | $40.31B | $23.55B | 1.71 |
| 2015-12-31 | $38.67B | $23.04B | 1.68 |
| 2015-09-30 | $39.10B | $23.24B | 1.68 |
| 2015-06-30 | $41.20B | $23.06B | 1.79 |
| 2015-03-31 | $41.21B | $24.33B | 1.69 |
| 2014-12-31 | $37.43B | $24.25B | 1.54 |
| 2014-09-30 | $37.76B | $24.29B | 1.55 |
| 2014-06-30 | $37.93B | $24.38B | 1.56 |
| 2014-03-31 | $37.34B | $24.35B | 1.53 |
| 2013-12-31 | $34.81B | $24.77B | 1.41 |
| 2013-09-30 | $35.46B | $24.81B | 1.43 |
| 2013-06-30 | $35.08B | $24.53B | 1.43 |
| 2013-03-31 | $35.09B | $24.32B | 1.44 |
| 2012-12-31 | $35.15B | $23.80B | 1.48 |
| 2012-09-30 | $32.00B | $23.82B | 1.34 |
| 2012-06-30 | $30.89B | $23.64B | 1.31 |
| 2012-03-31 | $28.97B | $23.53B | 1.23 |
| 2011-12-31 | $28.88B | $23.29B | 1.24 |
| 2011-09-30 | $28.83B | $23.72B | 1.22 |
| 2011-06-30 | $26.70B | $24.18B | 1.10 |
| 2011-03-31 | $26.94B | $23.98B | 1.12 |
| 2010-12-31 | $26.35B | $23.81B | 1.11 |
| 2010-09-30 | $26.67B | $24.36B | 1.10 |
| 2010-06-30 | $26.37B | $23.79B | 1.11 |
| 2010-03-31 | $26.66B | $24.52B | 1.09 |
| 2009-12-31 | $27.26B | $24.86B | 1.10 |
| 2009-09-30 | $26.63B | $22.87B | 1.17 |
| 2009-06-30 | $27.09B | $22.25B | 1.22 |
| 2009-03-31 | $27.91B | $21.51B | 1.30 |
| 2008-12-31 | $26.97B | $21.43B | 1.26 |
| 2008-09-30 | $28.09B | $21.67B | 1.30 |
| 2008-06-30 | $29.72B | $21.26B | 1.40 |
| 2008-03-31 | $30.05B | $21.50B | 1.40 |
| 2007-12-31 | $29.07B | $22.99B | 1.26 |
| 2007-09-30 | $29.23B | $23.67B | 1.24 |
| 2007-06-30 | $29.21B | $24.99B | 1.17 |
| 2007-03-31 | $28.35B | $25.14B | 1.13 |
| 2006-12-31 | $27.00B | $24.58B | 1.10 |
| 2006-09-30 | $27.34B | $24.14B | 1.13 |
| 2006-06-30 | $26.85B | $23.24B | 1.16 |
| 2006-03-31 | $27.25B | $24.11B | 1.13 |
| 2005-12-31 | $26.29B | $24.99B | 1.05 |
| 2005-09-30 | $20.62B | $21.24B | 0.97 |
| 2005-06-30 | $21.14B | $20.55B | 1.03 |
| 2005-03-31 | $20.49B | $20.00B | 1.02 |
| 2004-12-31 | $20.28B | $19.46B | 1.04 |
| 2004-09-30 | $7.34B | $6.80B | 1.08 |
| 2004-06-30 | $7.10B | $6.56B | 1.08 |
| 2004-03-31 | $7.57B | $6.36B | 1.19 |
| 2003-12-31 | $7.42B | $6.00B | 1.24 |
| 2003-09-30 | $7.35B | $5.85B | 1.26 |
| 2003-06-30 | $7.18B | $5.73B | 1.25 |
| 2003-03-31 | $7.03B | $5.48B | 1.28 |
| 2002-12-31 | $7.08B | $5.36B | 1.32 |
| 2002-09-30 | $6.91B | $5.33B | 1.30 |
| 2002-06-30 | $4.41B | $2.23B | 1.98 |
| 2002-03-31 | $4.28B | $2.13B | 2.01 |
| 2001-12-31 | $4.22B | $2.06B | 2.05 |
| 2001-09-30 | $3.92B | $2.18B | 1.80 |
| 2001-06-30 | $0.00B | 0.00 | |
| 2001-03-31 | $0.00B | 0.00 | |
| 2000-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $73.839B | $199.125B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $152.395B | 27.66 |
| HCA Healthcare (HCA) | United States | $117.237B | 18.18 |
| CVS Health (CVS) | United States | $96.896B | 11.14 |
| Cencora (COR) | United States | $68.317B | 21.55 |
| Natera (NTRA) | United States | $27.260B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.065B | 17.59 |
| DiDi Global (DIDIY) | China | $20.991B | 19.39 |
| Viatris (VTRS) | United States | $16.516B | 6.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.880B | 0.00 |
| Medpace Holdings (MEDP) | United States | $15.247B | 37.85 |
| Solventum (SOLV) | United States | $13.352B | 12.96 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $11.747B | 0.00 |
| ICON (ICLR) | Ireland | $11.741B | 11.65 |
| Revvity (RVTY) | United States | $11.283B | 19.63 |
| Charles River Laboratories (CRL) | United States | $9.041B | 17.41 |
| Sonic Healthcare (SKHHY) | Australia | $7.725B | 0.00 |
| Avantor (AVTR) | United States | $7.357B | 11.24 |
| BrightSpring Health Services (BTSG) | United States | $6.918B | 41.25 |
| HealthEquity (HQY) | United States | $6.768B | 25.31 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.996B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.813B | 38.16 |
| PACS (PACS) | United States | $5.774B | 35.11 |
| Sotera Health (SHC) | United States | $4.943B | 23.84 |
| Alignment Healthcare (ALHC) | United States | $4.232B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.016B | 18.82 |
| GeneDx Holdings (WGS) | United States | $2.430B | 42.68 |
| Organon (OGN) | United States | $2.106B | 2.22 |
| Establishment Labs Holdings (ESTA) | United States | $1.928B | 0.00 |
| Progyny (PGNY) | United States | $1.890B | 37.15 |
| Pediatrix Medical (MD) | United States | $1.789B | 10.68 |
| Surgery Partners (SGRY) | United States | $1.737B | 22.38 |
| Ardent Health (ARDT) | United States | $1.229B | 4.01 |
| InnovAge Holding (INNV) | United States | $1.014B | 149.40 |
| CareDx (CDNA) | United States | $0.944B | 15.42 |
| Teladoc Health (TDOC) | United States | $0.839B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.777B | 12.72 |
| Nutex Health (NUTX) | United States | $0.721B | 5.51 |
| Omada Health (OMDA) | United States | $0.694B | 0.00 |
| Embecta (EMBC) | United States | $0.620B | 3.46 |
| Sonida Senior Living (SNDA) | United States | $0.603B | 0.00 |
| Enhabit (EHAB) | United States | $0.558B | 25.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.548B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.464B | 8.53 |
| CryoPort (CYRX) | United States | $0.431B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.334B | 5.37 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Agilon Health (AGL) | United States | $0.262B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.259B | 0.00 |
| Oncology Institute (TOI) | United States | $0.241B | 0.00 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| LifeMD (LFMD) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| DocGo (DCGO) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.022B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.93 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |